Search results
Results from the WOW.Com Content Network
In December 2018, during a Q&A session with constituents on Twitter, Governor Wolf tweeted: "I think it is time for Pennsylvania to take a serious and honest look at legalizing recreational marijuana." [17] One month later, Wolf announced a statewide tour by Lieutenant Governor John Fetterman to gather public input on the idea. [18]
The drug or other substance has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse of the drug or other substances may lead to severe psychological or physical dependence. The complete list of Schedule II substances is as follows.
The use of cannabis in medicine began to decline by the end of the 19th century, due to difficulty in controlling dosages and the rise in popularity of synthetic and opium-derived drugs. [87] Also, the advent of the hypodermic syringe allowed these drugs to be injected for immediate effect, in contrast to cannabis which is not water-soluble and ...
The information state police provide the public through its website, psp.pa.gov, reports “According to the U.S. DOJ (Department of Justice), possession of a valid Medical Marijuana Card and/or ...
The drug or other substance has a potential for abuse less than the drugs or other substances in schedules I and II. The drug or other substance has a currently [1] accepted medical use in treatment in the United States. Abuse of the drug or other substance may lead to moderate or low physical dependence or high psychological dependence.
The data could help identify outliers who might be bending or breaking Pennsylvania’s medical marijuana law. Court orders Pa. health department to release doctor data for medical marijuana ...
This is the list of Schedule V controlled substances in the United States as defined by the Controlled Substances Act. [1] The following findings are required for substances to be placed in this schedule: [2] The drug or other substance has a low potential for abuse relative to the drugs or other substances in schedule IV.
For premium support please call: 800-290-4726 more ways to reach us